Target Information

Die Mebus MIM-Technik GmbH, headquartered in Neuhausen near Pforzheim, was founded in 2005 by Michael Mebus. The company has established itself as a leading specialist in Metal Injection Molding (MIM) and Ceramic Injection Molding (CIM), focusing on the design and variable series production of small, complex parts with tight tolerances.

The company is certified according to DIN EN ISO 13485:2016, positioning itself as a reliable strategic supplier for major medical technology companies. Their product offerings include high-quality surgical disposable items such as forceps for laparoscopic and endoscopic instruments, components for water jet surgery, and screws for orthodontic treatments. Additionally, Mebus serves clients from various sectors, including mechanical engineering, aerospace, and other areas of microtechnology.

Industry Overview

Germany has a robust industrial sector with a strong emphasis on precision engineering and advanced manufacturing technologies. The country is renowned for its engineering prowess and high-quality production standards, making it a global leader in sectors including automotive, aerospace, and medical technology. The demand for innovative and precise manufacturing processes has only increased in recent years as industries seek to develop more complex and efficient products.

In particular, the medical technology industry in Germany is experiencing significant growth, driven by advances in technology and an increasing elderly population requiring medical care. The industry is characterized by a high level of regulation and the necessity for adherence to stringent quality standards, which presents an opportunity for companies like Mebus that can meet these demands.

Furthermore, the trend towards minimally invasive surgical procedures has increased the need for specialized surgical instruments and disposables, reinforcing the importance of companies that excel in high-precision manufacturing. With the continued evolution of healthcare needs, suppliers who can provide innovative solutions are positioned for substantial growth.

As the German economy adapts to global market changes and technological advancements, sectors like microtechnology are becoming increasingly significant. This shift provides a favorable environment for companies that offer sophisticated solutions tailored to the needs of high-tech industries.

Rationale Behind the Deal

The successful sale of Mebus MIM-Technik GmbH to the Acrotec Group marks a strategic move for both parties. The deal underscores Mebus' potential for further growth as part of a larger entity with complementary capabilities and resources. Acrotec's experience in precision component manufacturing and its established position in the medical and high-precision industries are expected to enhance Mebus’ operational capabilities and broaden its market reach.

Adiuva Capital, which acquired a 75% stake in Mebus in 2018, has played a pivotal role in modernizing production processes, developing the management team, and expanding the customer portfolio. Their successful stewardship has prepared Mebus for this next growth phase under Acrotec's ownership, setting the stage for enhanced innovation and market competitiveness.

Investor Information

The Acrotec Group, a Swiss manufacturer of precision components, offers specialized services in the field of micromechanics. The group’s diverse manufacturing processes deliver “Swiss Made” quality products across various sectors, including watch-making, jewelry, medical technology, and high-precision technology for electronics, automotive, and aerospace industries. Currently, Acrotec employs over 2,800 staff and is well-positioned for continued growth.

Adiuva Capital GmbH is a Hamburg-based, owner-managed investment firm founded in 2011. It supports small and medium-sized enterprises in the German-speaking region with capital to foster sustainable growth. With a team of 13 professionals, Adiuva Capital manages entrepreneur capital exceeding €800 million, showcasing its commitment to empowering businesses through close collaboration.

View of Dealert

In evaluating the transaction, it can be posited that the acquisition of Mebus MIM-Technik GmbH by Acrotec represents a strategic investment that is likely to yield substantial long-term benefits. With Mebus' established reputation and expertise in precision manufacturing for medical technology, the deal aligns well with Acrotec's objectives to enhance its service offerings and market presence in this thriving sector.

The collaboration between Adiuva Capital and Mebus over the past years has undoubtedly strengthened the company’s foundations, making it an attractive target for acquisition. The operational improvements and expanded customer base achieved during this period suggest a company poised for significant growth. As a result, the integration into Acrotec's portfolio could accelerate Mebus' development and enable it to capitalize on the burgeoning opportunities in the medical device market.

Furthermore, Acrotec's extensive resources and expertise can facilitate innovation and efficiency improvements within Mebus, potentially leading to enhanced product offerings and increased competitive advantage. This aspect is crucial in the rapidly evolving landscape of medical technology.

Overall, the deal appears to be sound, with a strong strategic rationale and potential for growth, making it a compelling investment opportunity in the context of the medical technology industry.

View Original Article